Unraveling the complex genetics of familial combined hyperlipidemia

Elina Suviolahti1, Heidi E Lilja, Päivi Pajukanta

  • 1Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90095-7088, USA.

Annals of Medicine
|August 30, 2006
PubMed

Insights

Familial combined hyperlipidemia (FCHL) is a major risk for atherosclerosis. Recent research identified the upstream transcription factor 1 (USF1) gene as a key genetic contributor to FCHL susceptibility.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Metabolic Disorders

Background:

  • Familial combined hyperlipidemia (FCHL) is a prevalent genetic lipid disorder associated with atherosclerosis and coronary heart disease (CHD).
  • FCHL affects 1-6% of Western populations and is characterized by elevated total cholesterol and triglycerides.
  • Identifying genetic factors is crucial for understanding FCHL pathogenesis and improving risk assessment.

Purpose of the Study:

  • To elucidate the genetic underpinnings of familial combined hyperlipidemia (FCHL).
  • To identify specific genes and chromosomal regions associated with FCHL susceptibility.
  • To replicate findings from linkage and association studies in independent FCHL cohorts.

Main Methods:

  • Review of recent linkage and association studies for FCHL.
  • Analysis of candidate gene studies, including lipoprotein lipase (LPL) and APOA1/C3/A4/A5 gene cluster.
  • Fine-mapping of chromosomal region 1q21 and identification of the upstream transcription factor 1 (USF1) gene.

Main Results:

  • Replication of three chromosomal regions (1q21-23, 11p, 16q22-24.1) associated with FCHL.
  • Confirmation of the involvement of LPL and APOA1/C3/A4/A5 gene clusters.
  • Identification and replication of the USF1 gene on chromosome 1q21 as a significant contributor to FCHL.

Conclusions:

  • The upstream transcription factor 1 (USF1) gene is a key genetic factor underlying familial combined hyperlipidemia.
  • Further research is needed to determine the full spectrum of USF1 variants and their precise contribution to FCHL risk.
  • Understanding the genetic basis of FCHL is essential for developing targeted prevention and treatment strategies.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...